US$ 23.48
igtropin igf-1 lr3 (igf-1 L3) at Best Price in Philadelphia, Pennsylvania Receptor Grade IGF-1 LR3 -
Description
BPC-157 remains categorized strictly as an unapproved research compound reserved for laboratory evaluation

Benign prostatic hyperplasia (hypertrophy)

This drug and dosing regimen has demonstrated efficacy in non-human primates after high-dose radiation therapy (Farese 2012) and, as of this writing, Extimia is being evaluated in an open-label randomized phase II clinical study (BCD-017-2), which is expected to conclude in 2013 (ClinicalTrials.gov 2012a)

doi: 10.1016/j.molimm.2007.06.149
